We are leading the field of Regenerative Medicine and setting the gold standard for the next generation of healthcare. Today we are focusing on diseases of the Central Nervous System and we are working with two regenerative medicine solutions :

  1. Neural DrSC® based on a proprietary technology platform for the direct reprogramming of somatic cells to neural precursor cells
  2. Regeneration MatrixTM (RMxTM) based on a proprietary technology platform for the production of regenerative implants

Somatic cells are the “everyday” cells that make up our body. Somatic cells are ethical and do not involve the use of any embryonic or fetal cells or other material from these sources. We also use no animal components, viruses or bacteria in our production process.

How nature does it…

The Axolotl salamander is able to regrow brain and spinal cord tissue as well as entire limbs after injury and tissue loss. It achieves this by direct somatic cell reprogramming rather than recruiting circulating stem cells for regrowing tissue. The process starts with the formation of a regenerating blastema – composed of directly reprogrammed cells embedded in a matrix – that rebuilds and restores the area of damage including the original tissue architecture and organization.

We have successfully mimicked similar biological processes in vitro and are today able to manufacture directly reprogrammed neural precursor cells from somatic cells along with Regeneration MatrixTM.

We have developed and patented (patent pending) the first end-to-end fully automated manufacturing of cells, which allows us to rapidly scale-up production of reprogrammed cells for an unlimited number of patients on an annual basis.

We are also developing cell delivery and robotic injection systems, and functional rehabilitation systems that functionally activate the implanted cell.

OUR CORE TECHNOLOGY PLATFORMS

Neural DrSC®
Neural DrSC®
Regeneration Matrix™
Regeneration Matrix™
Fully Automated Cell manufacturing
Fully Automated Cell manufacturing